A detailed history of Kbc Group Nv transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Kbc Group Nv holds 18,972 shares of NBIX stock, worth $2.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
18,972
Previous 10,640 78.31%
Holding current value
$2.4 Million
Previous $1.47 Million 49.22%
% of portfolio
0.01%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$114.58 - $153.15 $954,680 - $1.28 Million
8,332 Added 78.31%
18,972 $2.19 Million
Q2 2024

Jul 17, 2024

BUY
$130.86 - $143.19 $19,890 - $21,764
152 Added 1.45%
10,640 $1.47 Million
Q1 2024

May 08, 2024

SELL
$130.4 - $143.74 $12,257 - $13,511
-94 Reduced 0.89%
10,488 $1.45 Million
Q4 2023

Feb 13, 2024

SELL
$106.07 - $132.76 $2.04 Million - $2.55 Million
-19,226 Reduced 64.5%
10,582 $1.39 Million
Q3 2023

Feb 15, 2024

SELL
$94.02 - $117.1 $1.19 Million - $1.49 Million
-12,685 Reduced 40.22%
18,852 $2.12 Million
Q2 2023

Feb 15, 2024

BUY
$89.53 - $104.87 $2.56 Million - $2.99 Million
28,555 Added 957.58%
31,537 $2.97 Million
Q2 2023

Jul 28, 2023

BUY
$89.53 - $104.87 $232,688 - $272,557
2,599 Added 9.55%
29,808 $2.81 Million
Q1 2023

Feb 14, 2024

SELL
$94.11 - $123.02 $76,040 - $99,400
-808 Reduced 2.79%
28,153 $2.85 Million
Q1 2023

May 04, 2023

BUY
$94.11 - $123.02 $2.29 Million - $3 Million
24,370 Added 858.4%
27,209 $2.75 Million
Q4 2022

Feb 14, 2024

BUY
$106.72 - $127.06 $2.77 Million - $3.3 Million
25,937 Added 857.71%
28,961 $3.46 Million
Q3 2022

Feb 15, 2024

SELL
$92.03 - $107.81 $699,428 - $819,356
-7,600 Reduced 71.82%
2,982 $317,000
Q2 2022

Feb 14, 2024

BUY
$75.79 - $100.07 $14,021 - $18,512
185 Added 6.52%
3,024 $295,000
Q1 2022

Feb 14, 2024

SELL
$72.45 - $94.81 $452,015 - $591,519
-6,239 Reduced 68.73%
2,839 $266,000
Q1 2022

May 06, 2022

SELL
$72.45 - $94.81 $452,015 - $591,519
-6,239 Reduced 68.73%
2,839 $266,000
Q4 2021

Feb 14, 2024

SELL
$79.65 - $106.22 $119,793 - $159,754
-1,504 Reduced 14.21%
9,078 $773,000
Q4 2021

Feb 03, 2022

SELL
$79.65 - $106.22 $247,153 - $329,600
-3,103 Reduced 25.47%
9,078 $773,000
Q2 2020

Aug 10, 2020

BUY
$85.09 - $130.36 $600,224 - $919,559
7,054 Added 137.59%
12,181 $1.49 Million
Q4 2019

Feb 11, 2020

BUY
$86.8 - $118.57 $445,023 - $607,908
5,127 New
5,127 $551,000
Q3 2019

Nov 07, 2019

SELL
$83.82 - $101.5 $9,220 - $11,165
-110 Closed
0 $0
Q2 2019

Dec 03, 2019

BUY
$72.24 - $91.27 $7,946 - $10,039
110 New
110 $10,000
Q2 2019

Jul 30, 2019

SELL
$72.24 - $91.27 $7,946 - $10,039
-110 Closed
0 $0
Q1 2019

Dec 03, 2019

BUY
$69.31 - $91.53 $7,624 - $10,068
110 New
110 $10,000
Q1 2019

May 10, 2019

SELL
$69.31 - $91.53 $7,624 - $10,068
-110 Closed
0 $0
Q4 2018

Dec 03, 2019

BUY
$68.32 - $124.36 $7,515 - $13,679
110 New
110 $8,000
Q4 2018

Jan 31, 2019

SELL
$68.32 - $124.36 $7,515 - $13,679
-110 Closed
0 $0
Q3 2018

Dec 03, 2019

BUY
$98.88 - $125.85 $10,876 - $13,843
110 New
110 $14,000
Q3 2018

Nov 14, 2018

SELL
$98.88 - $125.85 $10,876 - $13,843
-110 Closed
0 $0
Q2 2018

Dec 03, 2019

BUY
$75.3 - $105.99 $8,283 - $11,658
110 New
110 $11,000
Q2 2018

Aug 03, 2018

SELL
$75.3 - $105.99 $8,283 - $11,658
-110 Closed
0 $0
Q1 2018

Dec 03, 2019

BUY
$75.88 - $92.43 $8,346 - $10,167
110 New
110 $9,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.